Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Zixia Wu, Miao Miao, Yuhua Qiu, Zhenghong Qin, Jin Wang, Yiguo Jiang, Zhijun Ming & Xueguang Zhang. (2013) Association between polymorphisms in PDCD1 gene and aplastic anemia in Chinese Han population. Leukemia & Lymphoma 54:10, pages 2251-2254.
Read now
Read now
Konstantin Yakimchuk, Kutty Selva Nandakumar, Liying Chen, Rikard Holmdahl, Sam Okret & Mikael Jondal. (2012) Keratinocyte growth factor (KGF) delays the onset of collagen-induced arthritis. Autoimmunity 45:7, pages 510-515.
Read now
Read now
Sergio M Calixto & Chandra Mohan. (2007) Lupus genes at the interface of tolerance and autoimmunity. Expert Review of Clinical Immunology 3:4, pages 603-611.
Read now
Read now
Articles from other publishers (65)
Tingting Wang, Yanqing Ran, Yifei He, Lei Shi, Baizhao Zeng & Faqiong Zhao. (2023) Self-powered photoelectrochemical/visual sensing platform based on PEDOT/BiOBr0.8I0.2 organic-inorganic hybrid material and MWCNTs/SnS2 heterojunction for the ultrasensitive detection of programmed death ligand-1. Biosensors and Bioelectronics 237, pages 115558.
Crossref
Crossref
Michał Adamczyk, Joanna Bartosińska, Dorota Raczkiewicz, Anna Michalak-Stoma & Dorota Krasowska. (2023) The Impact of Biologic Treatment on PD-1/PD-L1 Pathway Disturbances in Psoriasis. Journal of Clinical Medicine 12:13, pages 4179.
Crossref
Crossref
Na Li, Geng Wang, Xin Hou, Risheng Tai, Shaogang Huang, Zhize He, Lei Lei, Suling Xu & Shanru Yang. (2022) Adverse and unconventional reactions related to immune checkpoint inhibitor therapy for cancer. International Immunopharmacology 108, pages 108803.
Crossref
Crossref
Moufida Ben Nasr, David Robbins, Philippe Parone, Vera Usuelli, Robert Tacke, Andy-Joe Seelam, Emily Driver, Thuy Le, Mohsen Sabouri-Ghomi, Lisa Guerrettaz, Daniel Shoemaker & Paolo Fiorina. (2022) Pharmacologically Enhanced Regulatory Hematopoietic Stem Cells Revert Experimental Autoimmune Diabetes and Mitigate Other Autoimmune Disorders. The Journal of Immunology 208:7, pages 1554-1565.
Crossref
Crossref
Peiyu Zhu, Jian Zhang, Yifei Yang, Lixun Wang, Jinpei Zhou & Huibin Zhang. (2021) Design, synthesis and biological evaluation of isoxazole-containing biphenyl derivatives as small-molecule inhibitors targeting the programmed cell death-1/ programmed cell death-ligand 1 immune checkpoint. Molecular Diversity 26:1, pages 245-264.
Crossref
Crossref
Adam Mor & Marianne Strazza. (2022) Bridging the Gap: Connecting the Mechanisms of Immune-Related Adverse Events and Autoimmunity Through PD-1. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Tal Goldberger, Gil Armoni, David Lavie, Sharon Merims, Alexander Maly & Rony Shreberk‐Hassidim. (2021) Pityriasis rubra pilaris induced by PD‐1 inhibitor nivolumab. International Journal of Dermatology 60:8, pages 1038-1039.
Crossref
Crossref
Candelaria Ponce de León, Pedro Lorite, Miguel Ángel López-Casado, Francisco Barro, Teresa Palomeque & María Isabel Torres. (2021) Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target. Frontiers in Immunology 12.
Crossref
Crossref
Sherine A. Bassiouni, Hanaa M. Abdeen, Heba K. Morsi, Maysaa E. Zaki, Maha Abdelsalam & Ola M. Gharbia. (2021) Programmed death 1 (PD-1) serum level and gene expression in recent onset systemic lupus erythematosus patients. The Egyptian Rheumatologist 43:3, pages 213-218.
Crossref
Crossref
Wilfried Posch, Doris Wilflingseder & Cornelia Lass-Flörl. (2020) Immunotherapy as an Antifungal Strategy in Immune Compromised Hosts. Current Clinical Microbiology Reports 7:3, pages 57-66.
Crossref
Crossref
Grażyna Sygitowicz & Dariusz Sitkiewicz. (2020) Cancer immunotherapy. Diagnostyka Laboratoryjna 55:1, pages 61-66.
Crossref
Crossref
Xin Lin, Xiang Lu, Guoshun Luo & Hua Xiang. (2020) Progress in PD-1/PD-L1 pathway inhibitors: From biomacromolecules to small molecules. European Journal of Medicinal Chemistry 186, pages 111876.
Crossref
Crossref
S M Abo El-khair, W Sameer, N Awadallah & D Shaalan. (2019) Programmed cell death 1 gene polymorphism as a possible risk for systemic lupus erythematosus in Egyptian females. Lupus 28:12, pages 1427-1434.
Crossref
Crossref
Kun Chen, Qian Xue, Fangfang Liu, Ling Liu, Caiyong Yu, Ganlan Bian, Kun Zhang, Chao Fang, Jun Song, Gong Ju & Jian Wang. (2019) B lymphocytes expressing high levels of PD-L1 are key regulators of diabetes development in non-obese diabetic mice. Molecular Immunology 114, pages 289-298.
Crossref
Crossref
Emi Furusawa, Tatsukuni Ohno, Shigenori Nagai, Taisei Noda, Takuya Komiyama, Katsunori Kobayashi, Hidetoshi Hamamoto, Michiyo Miyashin, Hiroo Yokozeki & Miyuki Azuma. (2019) Silencing of PD-L2/B7-DC by Topical Application of Small Interfering RNA Inhibits Elicitation of Contact Hypersensitivity. Journal of Investigative Dermatology 139:10, pages 2164-2173.e1.
Crossref
Crossref
Tatsuya Nagano, Motoko Tachihara & Yoshihiro Nishimura. (2019) Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer. Current Cancer Drug Targets 19:8, pages 595-630.
Crossref
Crossref
Li Fan, Yue Li, Jia-Yu Chen, Yong-Fa Zheng & Xi-Ming Xu. (2019) Immune checkpoint modulators in cancer immunotherapy: Recent advances and combination rationales. Cancer Letters 456, pages 23-28.
Crossref
Crossref
Christopher P Eades & Darius P H Armstrong-James. (2019) Invasive fungal infections in the immunocompromised host: Mechanistic insights in an era of changing immunotherapeutics. Medical Mycology 57:Supplement_3, pages S307-S317.
Crossref
Crossref
Anthony D. Honigman, Francis Lai, Joshua Elakis, Owen Prall, Michelle Goh & Christopher McCormack. (2019) Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient. Clinical Case Reports 7:4, pages 773-775.
Crossref
Crossref
David Cheishvili, Surabhi Parashar, Niaz Mahmood, Ani Arakelian, Richard Kremer, David Goltzman, Moshe Szyf & Shafaat A Rabbani. (2018) Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women. Journal of Bone and Mineral Research 33:11, pages 1980-1989.
Crossref
Crossref
Juliana Imgenberg-Kreuz, Jonas Carlsson Almlöf, Dag Leonard, Andrei Alexsson, Gunnel Nordmark, Maija-Leena Eloranta, Solbritt Rantapää-Dahlqvist, Anders A Bengtsson, Andreas Jönsen, Leonid Padyukov, Iva Gunnarsson, Elisabet Svenungsson, Christopher Sjöwall, Lars Rönnblom, Ann-Christine Syvänen & Johanna K Sandling. (2018) DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases 77:5, pages 736-743.
Crossref
Crossref
Claudia Freitas, Deborah Johnson & K. Weber. (2018) T Cell Calcium Signaling Regulation by the Co-Receptor CD5. International Journal of Molecular Sciences 19:5, pages 1295.
Crossref
Crossref
Yuko Hayashi, Takeshi Nishiyama, Masahiro Nakatochi, Shugo Suzuki, Satoru Takahashi & Mayumi Sugiura-Ogasawara. (2018)
Association of genetic variants of
PD1
with recurrent pregnancy loss
. Reproductive Medicine and Biology 17:2, pages 195-202.
Crossref
Crossref
D. Brandt, M. Sergon, S. Abraham, K. Mäbert & C.M. Hedrich. (2017) TCR + CD3 + CD4 − CD8 − effector T cells in psoriasis. Clinical Immunology 181, pages 51-59.
Crossref
Crossref
Zachary B. Davis, Daniel A. Vallera, Jeffrey S. Miller & Martin Felices. (2017) Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy. Seminars in Immunology 31, pages 64-75.
Crossref
Crossref
Jie Gao, Nan Gai, Li Wang, Kang Liu, Xing-Han Liu, Lin-Ting Wei, Tian Tian, Shan-Li Li, Yi Zheng, Yu-Jiao Deng, Zhi-Jun Dai & Rong-Guo Fu. (2017) Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk. Oncotarget 8:22, pages 36885-36897.
Crossref
Crossref
Hiroki TADANO & Toshihiko TORIGOE. (2017) Immune-related adverse events of immune checkpoint inhibitors. Japanese Journal of Clinical Immunology 40:2, pages 102-108.
Crossref
Crossref
Carolyn Rosinsky & Paul Andrew Antony. (2016) A role for pre-mNK cells in tumor progression. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Crossref
Mitali Bhattacharjee, Lavanya Balakrishnan, Santosh Renuse, Jayshree Advani, Renu Goel, Gajanan Sathe, T. S. Keshava Prasad, Bipin Nair, Ramesh Jois, Subramanian Shankar & Akhilesh Pandey. (2016) Synovial fluid proteome in rheumatoid arthritis. Clinical Proteomics 13:1.
Crossref
Crossref
Baihao ZhangShunsuke ChikumaShohei Hori, Sidonia FagarasanTasuku Honjo. (2016) Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model. Proceedings of the National Academy of Sciences 113:30, pages 8490-8495.
Crossref
Crossref
Shelley Ji Eun Hwang, Giuliana Carlos, Deepal Wakade, Karen Byth, Benjamin Y. Kong, Shaun Chou, Matteo S. Carlino, Richard Kefford & Pablo Fernandez-Penas. (2016) Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort. Journal of the American Academy of Dermatology 74:3, pages 455-461.e1.
Crossref
Crossref
Kek Chua, Lay Lian, Xiu Sim, Tien Cheah & Tze Lau. (2015) Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population. International Journal of Molecular Sciences 16:12, pages 9794-9803.
Crossref
Crossref
Y.H. Lee, S.-C. Bae, J.-H. Kim & G.G. Song. (2014) Meta-analysis of genetic polymorphisms in programmed cell death 1Metaanalyse von Genpolymorphismen beim programmierten Zelltod 1. Zeitschrift für Rheumatologie 74:3, pages 230-239.
Crossref
Crossref
Laura S. van Dam, Verena M. de Zwart & Friederike A.G. Meyer-Wentrup. (2015) The role of programmed cell death-1 (PD-1) and its ligands in pediatric cancer. Pediatric Blood & Cancer 62:2, pages 190-197.
Crossref
Crossref
Tom Seijkens, Pascal Kusters, Antonios Chatzigeorgiou, Triantafyllos Chavakis & Esther Lutgens. (2014) Immune Cell Crosstalk in Obesity: A Key Role for Costimulation?. Diabetes 63:12, pages 3982-3991.
Crossref
Crossref
Qingqing Jiao, Cuiping Liu, Ziliang Yang, Qiang Ding, Miaomiao Wang, Min Li, Tingting Zhu, Hua Qian, Wei Li, Na Tu, Fumin Fang, Licai Ye, Zuotao Zhao & Qihong Qian. (2014) Upregulated PD-1 Expression Is Associated with the Development of Systemic Lupus Erythematosus, but Not the PD-1.1 Allele of the PDCD1 Gene. International Journal of Genomics 2014, pages 1-6.
Crossref
Crossref
Haoyu Sun, Cheng Sun & Weihua Xiao. (2014) Expression regulation of co-inhibitory molecules on human natural killer cells in response to cytokine stimulations. Cytokine 65:1, pages 33-41.
Crossref
Crossref
Li Shi, Shaohua Chen, Lijian Yang & Yangqiu Li. (2013) The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies. Journal of Hematology & Oncology 6:1.
Crossref
Crossref
Yaping Han, Jun Li, Longfeng Jiang, Qingqing Xu, Bo Liu, Ke Jin, Yuan Liu & Zuhu Huang. (2013) Regulation of B7-H1 expression on peripheral monocytes and IFN-γ secretion in T lymphocytes by HBeAg. Cellular Immunology 283:1-2, pages 25-30.
Crossref
Crossref
Hanane el Bannoudi, Wanda G. H. Han, Jeroen N. Stoop, Pascale Louis‐Plence, Tom W. J. Huizinga & René E. M. Toes. (2013)
DX
5
+
CD
4
+
T
cells modulate
CD
4
+
T
‐cell response via inhibition of
IL
‐12 production by
DC
s
. European Journal of Immunology 43:2, pages 439-446.
Crossref
Crossref
N Asgari, C Nielsen, E Stenager, KO Kyvik & ST Lillevang. (2011) HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica. Multiple Sclerosis Journal 18:1, pages 23-30.
Crossref
Crossref
Narjes Soleimanifar, Ali Akbar Amirzargar, Mahdi Mahmoudi, Ali Akbar Pourfathollah, Esfandiar Azizi, Ahmad Reza Jamshidi, Nima Rezaei, Mohammad Taher Tahoori, Katayoon Bidad, Behrouz Nikbin & Mohammad Hossein Nicknam. (2010) Study of Programmed Cell Death 1 (PDCD1) Gene Polymorphims in Iranian Patients with Ankylosing Spondylitis. Inflammation 34:6, pages 707-712.
Crossref
Crossref
Yongjing Chen, Qin Wang, Bimin Shi, Ping Xu, Zhenhua Hu, Lixiong Bai & Xueguang Zhang. (2011) Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines. Cytokine 56:2, pages 231-238.
Crossref
Crossref
Wieger J. Norde, Frans Maas, Willemijn Hobo, Alan Korman, Michael Quigley, Michel G.D. Kester, Konnie Hebeda, J.H. Frederik Falkenburg, Nicolaas Schaap, Theo M. de Witte, Robbert van der Voort & Harry Dolstra. (2011) PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation. Cancer Research 71:15, pages 5111-5122.
Crossref
Crossref
Xiang Liu, Li-Hua Hu, Yi-Rong Li, Feng-Hua Chen, Yong Ning & Qun-Feng Yao. (2009) Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population. Rheumatology International 31:2, pages 209-213.
Crossref
Crossref
Jin-Kyong Chun, Dong Won Kang, Byung Won Yoo, Jeon-Soo Shin & Dong Soo Kim. (2009) Programmed death-1 (PD-1) gene polymorphisms lodged in the genetic predispositions of Kawasaki Disease. European Journal of Pediatrics 169:2, pages 181-185.
Crossref
Crossref
Wayne Truong, Wayne W Hancock, Jennifer C Plester, Shaheed Merani, David C Rayner, Govindarajan Thangavelu, Kenneth M Murphy, Colin C Anderson & A. M. James Shapiro. (2009) BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. Journal of Leukocyte Biology 86:1, pages 41-51.
Crossref
Crossref
Stephen C. Pflugfelder & Michael E. Stern. (2009) Immunoregulation on the Ocular Surface: 2nd Cullen Symposium. The Ocular Surface 7:2, pages 67-77.
Crossref
Crossref
Scherezade Momin, Sylvia Flores, Bárbara Angel B, Ethel Codner D, Elena Carrasco P & Francisco Perez-Bravo. (2009) Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes. Diabetes Research and Clinical Practice 83:3, pages 289-294.
Crossref
Crossref
MURAT ICEN, PAULO J. NICOLA, HILAL MARADIT-KREMERS, CYNTHIA S. CROWSON, TERRY M. THERNEAU, ERIC L. MATTESON & SHERINE E. GABRIEL. (2009) Systemic Lupus Erythematosus Features in Rheumatoid Arthritis and Their Effect on Overall Mortality. The Journal of Rheumatology 36:1, pages 50-57.
Crossref
Crossref
YH Lee, JH Woo, SJ Choi, JD Ji & GG Song. (2009) Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis. Lupus 18:1, pages 9-15.
Crossref
Crossref
Kenneth Murphy, Paul Travers & Mark Walport. 2009. Janeway Immunologie. Janeway Immunologie
753
823
.
Arlene T. Tieng & Elena Peeva. (2008) B-Cell-Directed Therapies in Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism 38:3, pages 218-227.
Crossref
Crossref
Luc Xerri, Bruno Chetaille, Nacer Seriari, Coralie Attias, Yves Guillaume, Christine Arnoulet & Daniel Olive. (2008) Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Human Pathology 39:7, pages 1050-1058.
Crossref
Crossref
Brian D. Juran & Konstantinos N. Lazaridis. (2008) Genetics and Genomics of Primary Biliary Cirrhosis. Clinics in Liver Disease 12:2, pages 349-365.
Crossref
Crossref
David A. Hokey, F. Brad Johnson, Jasmine Smith, Joshua L. Weber, Jian Yan, Lauren Hirao, Jean D. Boyer, Mark G. Lewis, George Makedonas, Michael R. Betts & David B. Weiner. (2008) Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques. European Journal of Immunology 38:5, pages 1435-1445.
Crossref
Crossref
Xian-Hui He, Qian-Tao Jia, Feng-Yao Li, Mark Saltis, Yi Liu, Li-Hui Xu & Qing-Bing Zha. (2008) CD8+ T cells specific for both persistent and non-persistent viruses display distinct differentiation phenotypes but have similar level of PD-1 expression in healthy Chinese individuals. Clinical Immunology 126:2, pages 222-234.
Crossref
Crossref
Brian D. Juran, Elizabeth J. Atkinson, Erik M. Schlicht, Brooke L. Fridley, Gloria M. Petersen & Konstantinos N. Lazaridis. (2007) Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology 47:2, pages 563-570.
Crossref
Crossref
Francesco Bifari, Veronica Lisi, Elda Mimiola, Annalisa Pasini & Mauro Krampera. (2008) Immune Modulation by Mesenchymal Stem Cells. Transfusion Medicine and Hemotherapy 35:3, pages 194-204.
Crossref
Crossref
Z. Fabry, E. Reinke, A. Zozulya, M. Sandor & I. Bechmann. 2008. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology
197
221
.
Delphine Sauce, Jorge R Almeida, Martin Larsen, Laurine Haro, Brigitte Autran, Gordon J Freeman & Victor Appay. (2007) PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS 21:15, pages 2005-2013.
Crossref
Crossref
Ronghua Ni, Kenji Ihara, Kenichi Miyako, Ryuichi Kuromaru, Mika Inuo, Hitoshi Kohno & Toshiro Hara. (2007) PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children. Human Genetics 121:2, pages 223-232.
Crossref
Crossref
R. J. Rigby, M. M. A. Fernando & T. J. Vyse. (2006) Mice, humans and haplotypes—the hunt for disease genes in SLE. Rheumatology 45:9, pages 1062-1067.
Crossref
Crossref
Kenneth M. Murphy, Christopher A. Nelson & John R. Šedý. (2006) Balancing co-stimulation and inhibition with BTLA and HVEM. Nature Reviews Immunology 6:9, pages 671-681.
Crossref
Crossref
Maya Gavrieli, John Sedy, Christopher A. Nelson,Kenneth M. Murphy. 2006.
157
185
.